Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles

Recombinant vaccine strain-derived measles virus (MV) is clinically tested both as vaccine platform to protect against other pathogens and as oncolytic virus for tumor treatment. To investigate the potential synergism in anti-tumoral efficacy of oncolytic and vaccine properties, we chose Ovalbumin a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Rep
Glavni autori: Hutzler, Stefan, Erbar, Stephanie, Jabulowsky, Robert A., Hanauer, Jan R. H., Schnotz, Jürgen H., Beissert, Tim, Bodmer, Bianca S., Eberle, Regina, Boller, Klaus, Klamp, Thorsten, Sahin, Ugur, Mühlebach, Michael D.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5715114/
https://ncbi.nlm.nih.gov/pubmed/29203786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-16928-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items